Anacin

Product NDC: 63736-200
11-digit product format: 637360200
Labeler code: 63736
Product ID: 63736-200_4895609d-1ec8-4ebd-8b6e-61ccd452ad5b
Type: HUMAN OTC DRUG
Nonproprietary name: Asprin and Caffeine
Dosage form: TABLET
Route: ORAL
Labeler: Insight Pharmaceuticals LLC
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2009-06-25
Substance: ASPIRIN; CAFFEINE
Active strength: 400; 32 mg/1; mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 6 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded package	package	63736-200	63736-200-04	D	Discontinued by firm	2026-10-20
excluded package	package	63736-200	63736-200-30	D	Discontinued by firm	2026-10-20
excluded package	package	63736-200	63736-200-50	D	Discontinued by firm	2026-10-20
excluded package	package	63736-200	63736-200-91	D	Discontinued by firm	2026-10-20
excluded package	package	63736-200	63736-200-92	D	Discontinued by firm	2026-10-20
excluded package	package	63736-200	63736-200-95	D	Discontinued by firm	2026-10-20

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 64 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Package NDC, Snapshot table
Captured / source date	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	63736-200-04	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	63736-200-30	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	63736-200-92	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	63736-200-50	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	63736-200-95	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	63736-200-91	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	63736-200-50	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	63736-200-92	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	63736-200-04	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	63736-200-30	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	63736-200-91	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	63736-200-95	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	63736-200-50	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	63736-200-92	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	63736-200-04	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	63736-200-30	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	63736-200-91	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	63736-200-95	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	63736-200-50	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	63736-200-92	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	63736-200-04	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	63736-200-30	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	63736-200-91	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	63736-200-95	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	63736-200-50	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	63736-200-92	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	63736-200-04	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	63736-200-30	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	63736-200-91	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	63736-200-95	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	63736-200-50	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	63736-200-92	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	63736-200-04	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	63736-200-30	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	63736-200-91	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	63736-200-95	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	63736-200-50	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	63736-200-92	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	63736-200-04	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	63736-200-30	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	63736-200-91	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	63736-200-95	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	63736-200-50	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	63736-200-92	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	63736-200-04	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	63736-200-30	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	63736-200-91	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	63736-200-95	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	63736-200-04	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	63736-200-91	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	63736-200-95	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	63736-200-30	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	63736-200-04	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	63736-200-91	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	63736-200-95	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	63736-200-30	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	63736-200-91	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	63736-200-04	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	63736-200-30	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	63736-200-95	`367a005e9d99…`	`383a685ebd0f…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Anacin
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ASPIRIN	400 mg/1
CAFFEINE	32 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
R16CO5Y76E	Internal UNII lookup
3G6A5W338E	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
198479	Internal RxNorm lookup
211292	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
7dea7767-9f52-b60a-5435-33cb9cc28bae	Product name	4	20250124
6338270f-96cb-0ecb-6fbb-0a9bc78001f4	Product name	7	20250116
0ca83774-3f79-b837-5d6f-c210102f3bc8	Product name	6	20250114
41b814f3-0166-1c53-c9ef-a0794c7daf9d	Product name	3	20221110
a590be26-846c-8659-a5a1-fb25907965dc	Product name	2	20221110
d7724692-1155-4cc8-a415-22f5fc4aec35	Product name	6	20220216
bde672ba-4805-28d0-1986-73543d41b412	Product name	2	20210201
2dc76302-91c0-4c35-ad78-99adfb049c4b	Product name	1	20200603
e6065d4b-5ae1-476f-a40e-f2851cbb5d2b	Product name	2	20180221
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
ade821ba-260a-47e2-bd89-743e27ac9906	Product name	1	20161121
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657	Product name	1	20150929
2a21311a-89e2-0e83-2ebd-117f9798b2b2	Product name	1	20140508
332e86c3-7875-ca6e-f934-2206d2b31996	Product name	1	20140508
56625fcc-aa34-9d30-d0e9-1c1beb37ea21	Product name	1	20140508
7dfac40f-a405-cd2e-7c06-3059ec0e1092	Product name	1	20140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94e	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508
d223c173-c39b-d764-47d4-d671d3088815	Product name	1	20140508
e01133ad-4dcd-c7f3-454b-2ff569ee160a	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
63736-200-04	Anacin	1 in 1 BOX	TABLET	1	9
63736-200-04	Anacin	4 in 1 BLISTER PACK	TABLET	4	9
63736-200-30	Anacin	1 in 1 BOX	TABLET	1	9
63736-200-30	Anacin	30 in 1 BOTTLE	TABLET	30	9
63736-200-50	Anacin	1 in 1 BOX	TABLET	1	9
63736-200-50	Anacin	50 in 1 BOTTLE	TABLET	50	9
63736-200-90	Anacin	100 in 1 BOTTLE	TABLET	100	9
63736-200-90	Anacin	1 in 1 BOX	TABLET	1	9
63736-200-91	Anacin	1 in 1 BOX	TABLET	1	9
63736-200-91	Anacin	130 in 1 BOTTLE	TABLET	130	9
63736-200-92	Anacin	125 in 1 BOX	TABLET	125	9
63736-200-92	Anacin	1 in 1 POUCH	TABLET	1	9
63736-200-93	Anacin	300 in 1 BOTTLE	TABLET	300	9
63736-200-93	Anacin	1 in 1 BOX	TABLET	1	9
63736-200-95	Anacin	750 in 1 BOX	TABLET	750	9
63736-200-95	Anacin	1 in 1 POUCH	TABLET	1	9

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Aspirin	ACTIVE INGREDIENT	R16CO5Y76E	ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS]	2
Caffeine	ACTIVE INGREDIENT	3G6A5W338E	ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS]	2
Aspirin	ACTIVE MOIETY	R16CO5Y76E	ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS]	2
Caffeine	ACTIVE MOIETY	3G6A5W338E	ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS]	2
cellulose, microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS]	2
hypromelloses	INACTIVE INGREDIENT	3NXW29V3WO	ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS]	2
sodium lauryl sulfate	INACTIVE INGREDIENT	368GB5141J	ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63736-200	ANACIN (ASPRIN AND CAFFEINE) TABLET [INSIGHT PHARMACEUTICALS LLC]	8	Current NDC, Legacy NDC, 16 package rows	20250115_51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 32 of 79 · 1,579 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Low Dose Aspiriun	ASPIRIN	AMERIFOODS TRADING COMPANY	3802c96a-5e2a-ba9c-e063-6394a90abb78	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief	ACETAMINOPHEN	HYVEE INC	4227aeb1-dd2c-9ca1-e063-6294a90ad709	2025-11-20	Warnings	Exact identifier application number: M013
good sense pain relief	ACETAMINOPHEN	NuCare Pharamceuticals, Inc.	440c13d7-edf0-f611-e063-6394a90af995	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief	ACETAMINOPHEN	HYVEE INC	4227a2cc-69fa-869d-e063-6294a90a1d41	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief	ACETAMINOPHEN	HYVEE INC	422796ed-7558-f7e8-e063-6294a90ad1c7	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief	ACETAMINOPHEN	HYVEE INC	3e61abe4-b4be-01af-e063-6394a90a8b24	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief PM	ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE	HYVEE INC	3e60703b-a5cf-333a-e063-6394a90a2087	2025-11-20	Warnings	Exact identifier application number: M013
ASPIRIN	ASPIRIN	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED	54e4ae54-caf8-4105-8428-256f56a2f68f	2025-11-19	Warnings	Exact identifier application number: M013
MIDOL COMPLETE	ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE	R J General Corporation	0c09a178-1a07-4079-b4a6-d1657cb8e714	2025-11-17	Warnings	Exact identifier application number: M013
Alka-Seltzer Original	ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE	R J General Corporation	dbb0d067-71f0-45e4-bc98-548cf4a90b3a	2025-11-17	Warnings	Exact identifier application number: M013
MOTRIN IB	IBUPROFEN	R J General Corporation	afa87bb5-7fcb-4ccd-acac-f7931242181f	2025-11-17	Warnings	Exact identifier application number: M013
TYLENOL EXTRA STRENGTH	ACETAMINOPHEN	R J General Corporation	99e45e83-37a3-44df-9a2a-98ba7457a5bb	2025-11-17	Warnings	Exact identifier application number: M013
TYLENOL PM EXTRA STRENGTH	ACETAMINOPHEN	R J General Corporation	a40ea0e3-d666-4605-b5e0-beeaf8f586f2	2025-11-17	Warnings	Exact identifier application number: M013
Acetaminophen 250 mg and Ibuprofen 125 mg	ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG	R J General Corporation	68d3be55-9340-4cc9-a05a-12b9338ddc56	2025-11-17	Warnings	Exact identifier application number: M013
Ibuprofen 200 mg	IBUPROFEN	R J General Corporation	dd9aaf80-6c2b-41a3-87b9-61642aaed4f0	2025-11-17	Warnings	Exact identifier application number: M013
Ibuprofen 200 mg	IBUPROFEN	R J General Corporation	1c18a2da-1718-4c00-aea8-9fb4a3418312	2025-11-17	Warnings	Exact identifier application number: M013
Ibuprofen 200 mg	IBUPROFEN	R J General Corporation	cd3060a5-3b90-42e4-89cd-3b620859045f	2025-11-17	Warnings	Exact identifier application number: M013
Ibuprofen 200 mg	IBUPROFEN	R J General Corporation	1c7221ae-52d1-4d18-b586-c47ff656150d	2025-11-17	Warnings	Exact identifier application number: M013
Excedrin Extra Strength Headache	ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE	R J General Corporation	907c89e7-2482-465f-9f85-2381ecab1b86	2025-11-17	Warnings	Exact identifier application number: M013
Bayer Genuine Aspirin	ASPIRIN	R J General Corporation	23daa359-d40f-4f64-81be-6d154f41df9f	2025-11-17	Warnings	Exact identifier application number: M013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R16CO5Y76E	ASPIRIN	50-78-2	ASPIRIN
3G6A5W338E	CAFFEINE	58-08-2	CAFFEINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
211292	ANACIN 400 MG / 32 MG Oral Tablet	PSN	51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff	9
198479	aspirin 400 MG / caffeine 32 MG Oral Tablet	PSN	51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff	9
211292	aspirin 400 MG / caffeine 32 MG Oral Tablet [Anacin]	SBD	51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff	9
198479	aspirin 400 MG / caffeine 32 MG Oral Tablet	SCD	51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff	9
211292	Anacin (ASA 400 MG / caffeine 32 MG) Oral Tablet	SY	51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff	9
198479	ASA 400 MG / Caffeine 32 MG Oral Tablet	SY	51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff	9
211292	ASA 400 MG / Caffeine 32 MG Oral Tablet [Anacin]	SY	51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff	9

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
63736-200-04	63736020004	1 BLISTER PACK in 1 BOX (63736-200-04) > 4 TABLET in 1 BLISTER PACK	1 blister pack	2009-06-25	2023-06-30	No	No	Current
63736-200-30	63736020030	1 BOTTLE in 1 BOX (63736-200-30) > 30 TABLET in 1 BOTTLE	1 bottle	2009-06-25	2023-06-30	No	No	Current
63736-200-50	63736020050	1 BOTTLE in 1 BOX (63736-200-50) > 50 TABLET in 1 BOTTLE	1 bottle	2009-06-25	0000-00-00	No	No	Current
63736-200-90	63736020090	1 BOTTLE in 1 BOX (63736-200-90) / 100 TABLET in 1 BOTTLE	1 bottle	2009-06-25	0000-00-00	No	No	Current
63736-200-91	63736020091	1 BOTTLE in 1 BOX (63736-200-91) > 130 TABLET in 1 BOTTLE	1 bottle	2009-06-25	2023-06-30	No	No	Current
63736-200-92	63736020092	125 POUCH in 1 BOX (63736-200-92) > 1 TABLET in 1 POUCH	125 pouch	2009-06-25	0000-00-00	No	No	Current
63736-200-93	63736020093	1 BOTTLE in 1 BOX (63736-200-93) / 300 TABLET in 1 BOTTLE	1 bottle	2009-06-25	0000-00-00	No	No	Current
63736-200-95	63736020095	750 POUCH in 1 BOX (63736-200-95) > 1 TABLET in 1 POUCH	750 pouch	2009-06-25	2023-06-30	No	No	Current